.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research into the Pathogen Hypothesis of Alzheimer's examines how infectious agents might contribute to dementia. While the 2024 Lancet Commission identified 14 modifiable risk factors, it omitted pathogens due to causality debates. However, new quantitative analyses suggest that viruses and bacteria play a significant role in neuroinflammation and amyloidogenesis.
Researchers utilized nationwide cohort studies to apply a Population Attributable Fraction (PAF) model. This study specifically evaluated pathogens such as Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis, and Chlamydia pneumoniae. Findings suggest that infectious agents could account for 19% to 31% of cases in single-pathogen models. In joint models of sporadic cases, this burden expands to a range of 31% to 52%.
The study also highlights a synergistic interaction with the APOE ε4 allele. Furthermore, investigators addressed failures in antimicrobial clinical trials like VALAD and GAIN. They argue that these results demonstrate a need for precision biomarker stratification rather than a refutation of the hypothesis. Consequently, integrating pathogen suppression into prevention protocols may be vital for future care.
Key pathogens include Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis (associated with gum disease), and Chlamydia pneumoniae.
Experts suggest these trials likely failed because they lacked precision biomarker stratification to identify patients most likely to benefit from treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Bender O et al. Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease. J Alzheimers Dis. 2026 May 11. doi: 10.1177/13872877261447530. PMID: 42115784.
Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Commission. Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0.
Itzhaki RF et al. Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016;51(4):979-84. doi: 10.3233/JAD-160152.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New quantitative models suggest infectious pathogens contribute significantly to Alzheimer's disease burden, potentially accounting for up to 52% of cases....
5 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
